ArticleScientific reports2025
Investigating the potential selective effects of a Kiperin multi-component magnesium supplement on colon cancer and normal cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigation of the effects of a Kiperin Bromelain & Papain complex in normal colon, mammary, and skin cells.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnesium is vital for numerous cellular processes and has demonstrated therapeutic potential in various physiological and pathological contexts. Colorectal cancer remains a major cause of cancer-related mortality worldwide. This study evaluates the effects of a multi-component magnesium supplement on human colon fibroblasts (CCD-18Co) and colon cancer cells (HCT-116). CCD-18Co and HCT-116 cells were treated with 2.5 μL dose of the Kiperin multi-component magnesium supplement. Cell viability was assessed via cell counting, and migration was analyzed using wound healing assays. Oxidative stress was evaluated by measuring total oxidant status (TOS) and total antioxidant status (TAS). Gene expression levels of VDR and TNFα genes were measured by Real-Time PCR. Magnesium complex supplementation significantly reduced HCT-116 viability (p < 0.001) while enhancing CCD-18Co proliferation (p < 0.01). Cell migration increased in CCD-18Co cells at 18 h (p < 0.05), while HCT-116 migration decreased at 6 h (p < 0.05) and increased at 18 h. TOS levels were significantly decreased in both cell lines, indicating reduced oxidative stress. Additionally, magnesium supplementation upregulated VDR expression and downregulated TNFα in CCD-18Co cells. Similarly, in HCT-116 colon cancer cells, VDR expression was significantly increased, whereas TNFα expression showed no statistically significant change. Magnesium supplement may exert selective effects by inhibiting colon cancer cell survival while supporting proliferation and anti-inflammatory signaling in normal colon cells. These findings highlight its potential utility in colon cancer prevention and gut health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.